Grant: Engage Grants Program
University of Calgary
$25,000.00
Engineering of Transferase Enzymes for DNA Synthesis**
EF 2018-19
Résumé
DNA sequencing technology has dropped the price of reading DNA over 10,000 times in 10 years. The bottleneck of synthetic biology is now writing (i.e. synthesizing) DNA. Startups in three major economies (US, France, UK) are working on next-generation enzymatic DNA synthesis technology to replace the current chemical technology. Currently, the only commercially viable method is a two-step process developed in the 1970s. This method chemically synthesizes short DNA fragments and assembles them in an error-prone and time-consuming step. This process takes an order of magnitude longer and is responsible for an estimated 1,200,000 litres of hazardous chemical waste per year, including acetonitrile, trichloroacetic acid, toluene, tetrahydrofuran, and pyridine. Using enzymes will reduce the cost and turnaround time for synthetic DNA significantly which is crucial for research labs to stay competitive. The proposed innovation is the determination of the structures and activities of existing DNA synthesis enzymes in nature. This will guide the design of novel enzymes capable of making arbitrary sequences of DNA. Preliminary work has been done by Dr. Chao Chen and documented in an internal report. Structure determination will be carried out in the labs of Professor Alexei Savchenko who oversees research groups at the University of Calgary and University of Toronto. Dr. Brendan Hussey will be hired by Spindle Biotech Inc. to assist with activity screening. The partner company, Spindle Biotech, is a Canadian-owned company solely focused on developing Canadian technology for enzymatic DNA synthesis. The enzymes designed in this project and subsequent proteins engineering will be incorporated into a DNA synthesizer being developed in parallel. The implications are far reaching, including public health and national security.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
537088-2018
Name nom
Savchenko, Alexei
Department département
Microbiology and Infectious Diseases
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5000
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Genetics
Research subject fr
Génétique
Partie
1
Nb partie
1
Application title
Engineering of Transferase Enzymes for DNA Synthesis**
Keyword
NSERC
Application summary
DNA sequencing technology has dropped the price of reading DNA over 10,000 times in 10 years. The bottleneck of synthetic biology is now writing (i.e. synthesizing) DNA. Startups in three major economies (US, France, UK) are working on next-generation enzymatic DNA synthesis technology to replace the current chemical technology. Currently, the only commercially viable method is a two-step process developed in the 1970s. This method chemically synthesizes short DNA fragments and assembles them in an error-prone and time-consuming step. This process takes an order of magnitude longer and is responsible for an estimated 1,200,000 litres of hazardous chemical waste per year, including acetonitrile, trichloroacetic acid, toluene, tetrahydrofuran, and pyridine. Using enzymes will reduce the cost and turnaround time for synthetic DNA significantly which is crucial for research labs to stay competitive. The proposed innovation is the determination of the structures and activities of existing DNA synthesis enzymes in nature. This will guide the design of novel enzymes capable of making arbitrary sequences of DNA. Preliminary work has been done by Dr. Chao Chen and documented in an internal report. Structure determination will be carried out in the labs of Professor Alexei Savchenko who oversees research groups at the University of Calgary and University of Toronto. Dr. Brendan Hussey will be hired by Spindle Biotech Inc. to assist with activity screening. The partner company, Spindle Biotech, is a Canadian-owned company solely focused on developing Canadian technology for enzymatic DNA synthesis. The enzymes designed in this project and subsequent proteins engineering will be incorporated into a DNA synthesizer being developed in parallel. The implications are far reaching, including public health and national security.